News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Symphogen A/S to Present at Annual J.P. Morgan Healthcare Conference


1/3/2013 9:59:21 AM

Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment diseases such as cancer or infectious and autoimmune diseases, today announced that the company is scheduled to present next Monday, 7 January at 8 am PT in the Elizabethan C/D Ballroom of the Westin St. Francis Hotel at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES